Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicament composition for treating cardiac and cerebral vascular disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for cardiovascular and cerebrovascular diseases and compositions, which can be used in cardiovascular system diseases, drug combinations, pharmaceutical formulations, etc., and can solve the problems of large and unsafe drug use.
Inactive Publication Date: 2012-06-27
GUIZHOU XINBANG PHARMACEUTICAL CO LTD
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] The purpose of the present invention is to combine two drugs that act on different targets and can significantly reduce the infarct area of the brain tissue and significantly reduce the behavioral disorder caused by brain tissuenecrosis. Since the drug interaction is a synergistic interaction, And it is stronger than the additive effect of individual drugs; it solves the problem of unsafe drug dosage; it makes the drugcurative effect faster and stronger
The purpose of the present invention is to address the above-mentioned deficiencies in the prior art, and to provide a kind of pharmaceutical composition for the treatment of ischemic cerebrovascular disease, mainly in order to solve the problem of using ginsenoside or safflower yellow alone as a method for treating ischemic cerebrovascular disease. Various problems in vascular diseases, specific receptors manipulate Ca 2+ Combined use of channel blockerginsenoside Rd and platelet activating factor receptorantagonistsafflower yellow
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0063] Take ginsenoside-Rd, safflower yellow A, sodiumchloride, 1,2-propanediol; dissolve sodiumchloride to 500ml of 20% propylene glycolaqueous solution, add ginsenoside-Rd, safflower yellow A, at 60~70℃ Stir on a water bath until fully dissolved, cool to room temperature, add the remaining amount of water for injection to 1000ml, mix well and filter with a 0.22μm filter membrane. The filtrate is filled in separate bottles, sealed, and sterilized to obtain the product.
Embodiment 2
[0064] The preparation of embodiment 2 dropping pills
[0071] Take polyethylene glycol 6000, put it in a container, heat it to 70-80°C, wait until it is completely melted, and when the temperature drops to about 50°C, add ginsenoside-Rd and safflower yellow A to melt, and control the temperature at 40°C -50°C, pour it into a dropping pillmachine and drop it into simethicone oil to make a dropping pill.
Embodiment 3
[0072] Example 3 Preparation of Sublingual Tablets
[0082] 2. Take ginsenoside-Rd, safflower yellow A, hydroxypropyl methylcellulose (E-50), hydroxypropyl methylcellulose (E-4M), hydroxypropyl cellulose, micropowder silica gel, hard Magnesiumfatty acid is mixed evenly by the method of increasing in equal amounts, and directly compressed into sublingual lozenges, to obtain.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of medicine and discloses a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases. The pharmaceutical composition is prepared by ginsenoside and carithamine as main ingredients and can be prepared into pharmaceutically or clinically acceptable dosage forms. The pharmaceutical composition has functions of expanding blood vessels of brain, reducing cerebral vascular resistance, increasing cerebral blood flow, obviously minimizing infarct area of brain tissues, obviously lightening behavior disorders caused by brain tissuenecrosis, and the like, and can be used for preparing medicaments for treating diseases such as cerebral circulation insufficiency, cerebral thrombosis, cerebral embolism, brain blood vessels spasm,brain insufficiency, senile dementia, Parkinsonism, cerebral apoplexy, hypertension, hyperlipemia, arteriosclerosis, coronary heart disease, angina pectoris, miocardial infarction, etc.
Description
Technical field: [0001] The invention relates to a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, which is made of ginsenoside and safflower yellow and belongs to the technical field of medicines. Background technique: [0002] Cerebral thrombosis, cerebral arteriosclerosis, coronary heart disease, angina pectoris and other cardiovascular and cerebrovascular diseases seriously threaten human life and health. According to epidemiological investigations, the incidence and death of cardiovascular and cerebrovascular diseases have The incidence rate of cardiovascular and cerebrovascular diseases in the world is 1.4-200 / 100,000 population, and the average death rate is 100 / 100,000 population. The mortality rate of cardiovascular and cerebrovascular diseases in my country has leapt to the top top of the list of diseases. Therefore, it is very necessary to carry out research on therapeutic drugs, and it is also a hot spot of research at home and...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More